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Analysis of partial nucleotide sequences of 22 West
Nile virus (WNV) isolates collected during the summer and
fall of 2001 and 2002 indicated genetic variation among
strains circulating in geographically distinct regions of the
United States and continued divergence from isolates col-
lected in the northeastern United States during 1999 and
2000. Sequence analysis of a 2,004-nucleotide region
showed that 14 isolates shared two nucleotide mutations
and one amino acid substitution when they were compared
with the prototype WN-NY99 strain, with 10 of these iso-
lates sharing an additional nucleotide mutation. In compar-
ison, isolates collected from coastal regions of southeast
Texas shared the following differences from WN-NY99: five
nucleotide mutations and one amino acid substitution. The
maximum nucleotide divergence of the 22 isolates from
WN-NY99 was 0.35% (mean = 0.18%). These results show
the geographic clustering of genetically similar WNV iso-
lates and the possible emergence of a dominant variant cir-
culating across much of the United States during 2002.
W
est Nile virus (WNV) is a member of the genus
Flavivirus (family Flaviviridae) and belongs to the
Japanese encephalitis virus serocomplex. Until 1999, the
geographic distribution of the virus was limited to Africa,
the Middle East, India, and western and central Asia with
occasional epidemics in Europe (1,2). By December 2002,
however, the distribution of the virus had expanded to
include 44 states of the continental United States and
southern regions of 5 Canadian provinces from
Saskatchewan to Nova Scotia (3). Over the course of 3
years, the virus has traversed North America, presumably
from New York City, where it was first isolated during the
summer of 1999 (4–7). Partial nucleotide and complete
genome sequence analysis of several WNV strains isolated
in the northeastern United States during 1999 and 2000
showed that these isolates were most closely related to a
WNV strain isolated from the brain of a dead goose in
Israel in 1998 (6,8,9). The subsequent establishment of
WNV across the eastern and midwestern regions of North
America from 1999 through 2001 set the stage for the
rapid and widespread movement of the virus across the
remainder of the continent during the summer of 2002,
resulting in the highest number of annual case reports and
deaths attributed to WNV in humans, equines, and birds
documented since the discovery of the virus in North
America. Surveillance programs initiated by public health
agencies, research institutions, and diagnostic laboratories
have resulted in the collection of hundreds of WNV iso-
lates across the United States and Canada from various
sources, including mosquitoes, humans, equines, birds,
and a number of other vertebrate species (3). 
Phylogenetic comparisons of partial and complete
nucleotide sequences from isolates collected in the north-
eastern United States during 1999 and 2000 demonstrated
a high degree of genetic similarity to the prototype New
York strain, WN-NY99 (GenBank accession no.
AF196835), with nucleotide identities of >99.8% and
amino acid identities of >99.9% (9–12). Although these
studies have confirmed that northeastern isolates collected
in 1999 and 2000 showed limited genetic divergence from
WN-NY99, to date little published information has
described the continuing divergence of WNV as its tempo-
ral and spatial distribution have expanded (13). To assess
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Birmingham, Alabama, USAthe extent to which WNV has evolved since its introduc-
tion in North America, we analyzed the partial nucleotide
and deduced amino acid sequences of WNV isolates col-
lected during the summer and fall of 2001 and 2002 and
compared them to a homologous sequence region of WN-
NY99. Collaborations between the University of Texas
Medical Branch (UTMB) and a number of U.S. public
health agencies have allowed 22 isolates of WNV to be
collected, representing several geographically distinct U.S.
regions. Phylogenetic comparisons of a 2,004-nucleotide
region encoding the entire premembrane and envelope
proteins (prM-E) of each isolate have shown the most
divergent variants of WNV in North America to date and
provide evidence of the possible emergence of a dominant
variant circulating in many regions of the United States.
Furthermore, our results indicate geographic clustering of
distinct variants within and between states and reinforce
previous evidence supporting the likelihood of multiple
introductions of virus into the state of Texas (13).
Materials and Methods
Collection and Virus Isolation
Isolates were collected from five states: Illinois,
Alabama, Louisiana, Colorado, and Texas. Isolates from
Texas were collected from nine counties representing
regions across the entire state (Figure 1). All isolates were
collected from September 2001 to October 2002. After
being confirmed WNV-positive by state public health lab-
oratories, virus or tissues were sent to UTMB for submis-
sion into the World Arbovirus Reference Collection. Each
sample was given one passage in Vero cells to derive virus-
es for use in these studies. Virus samples represented a
variety of sources, including mosquito pools, bird brain,
human cerebrospinal fluid (CSF), and a dog kidney. Of the
18 isolates sequenced in this study (Table 1), 11 were iso-
lated from mosquito pools by the Texas Department of
Health (TDH); 2 from a mosquito pool and dog kidney
homogenate by the Illinois Natural History Survey
(INHS); 2 from passerine brain homogenates from the
University of Alabama at Birmingham; 1 from a red-tailed
hawk brain homogenate by the Centers for Disease Control
and Prevention, Division of Vector-Borne Infectious
Diseases (CDC-DVBID), Fort Collins, Colorado; 1 from a
mosquito pool in Louisiana, courtesy of CDC-DVBID;
and 1 from the CSF of a patient who died of West Nile
encephalitis at UTMB. 
RNA Extraction, Reverse Transcription, 
and Polymerase Chain Reaction 
Viral RNA was extracted directly from 140 µLo f
infected Vero or BHK cell culture supernatants by using
the QiaAMP viral RNA extraction kit (Qiagen, Valencia,
CA). Reverse transcription (RT) was performed in a 50-µL
volume containing 5 µL of viral RNA, 1 µL of random
hexamer primer, 10 µL of 5X RT buffer, 4 µL of 10 mM
dNTPs, 0.4 µL of cloned RNAse inhibitor, 0.5 µLo f
Moloney murine leukemia virus (MMLV) reverse tran-
scriptase, and 29.1 µL of high-performance liquid chro-
matography (HPLC) water. Polymerase chain reaction
(PCR) was performed in a 25-µL volume containing 2.0
µL cDNA template from RT, 1.0 µL forward primer, 1.0
µL reverse primer, 2.5 µL 10X PCR buffer, 0.5 µL 10 mM
dNTPs, 0.5 µL of 1 U/µL Taq PCR, and 17.5 µL of HPLC
water. Three previously described primer pairs were used
to amplify the entire prM-E genes of WNV (13). PCR
products were gel-purified by using the QIAquick kit
(Qiagen), according to the manufacturer’s protocol, and
the resulting template was directly sequenced by using the
amplifying primers. The WN1751/WN2504A PCR prod-
uct derived from WNV isolate Galveston County, TX-3
was cloned into pGEM-T Easy (Promega Corporation,
Madison, WI), and 10 clones were sequenced to determine
the degree of nucleotide sequence divergence within a sin-
gle isolate collected from the southeast coast of Texas.
Sequencing reactions were performed in the UTMB
Biomolecular Resource Facility’s DNAsequencing labora-
tory by previously described methods (13). Analysis and
assembly of sequencing data were performed by using the
Vector NTI Suite software package (Informax, Frederick,
MD). Nucleotide and deduced amino acid sequences of the
entire prM-E genes from each isolate were aligned by
using the AlignX program in the Vector NTI Suite and
compared with previously published sequences of isolates
from southeast Texas collected from June to August of
2002 (13). All isolates were then compared with isolates
collected in the northeastern United States during 1999,
2000, and 2001, and a phylogenetic tree was constructed
by maximum parsimony algorithm by using PAUP
(Version 4.0b10) (Sinauer Associates, Sunderland, MA) to
show genetic relationships of these isolates with other
North American WNV isolates found in GenBank, in
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Figure 1. Locations of collected isolates, 2001–2002.which the homologous 2,004-nucleotide region had been
sequenced.
Results
Nucleotide sequences representing a 2,004-nucleotide
region of the complete prM-E genes of WNV (nucleotides
466–2,469) of the 18 isolates collected in 2001 and 2002
(GenBank AY4281514–AY428531), plus 4 southeast
Texas strains (13), were compared with a homologous
sequence region of the prototype WNV, WN-NY99
(Tables 1 and 2). Of the 22 isolates analyzed, 16 were col-
lected from 10 different Texas counties, and 2 each from
Illinois and Alabama, plus 1 each from Colorado and
Louisiana. All isolates were from 2002, except 2 that came
from Alabama in 2001 (Figure 1). Sequence alignments
comparing WN-NY99 with individual 2001 and 2002 iso-
lates showed up to seven nucleotide mutations and three
amino acid substitutions among the 22 isolates analyzed
(Tables 1 and 2). Nucleotide mutations occurred at 33 posi-
tions (9 in prM, 24 in E) with a total of 7 amino acid sub-
stitutions (2 in prM, 5 in E). The maximum nucleotide
divergence of the 22 isolates from WN-NY99 was 0.35%,
with an average nucleotide divergence of 0.18%.
Several of the nucleotide mutations identified in this
study were shared by many isolates (Table 1 and 2;
Figure 2). Two nucleotide mutations at residues 1,442
(conservative amino acid substitution of Val to Ala at posi-
tion E159) and 2,466 were shared by 14 of the 22 isolates,
with 10 of these 14 isolates sharing an additional noncod-
ing nucleotide mutation at residue 660. Five different
nucleotide mutations (at residues 969, 1,192 [amino acid
substitution of Thr to Ala at position E76], 1,356, 2,154,
and 2,400) were shared by seven isolates, all of which were
collected from coastal regions of southeast Texas. The iso-
late from Louisiana differed from WN-NY99 at only one
nucleotide (residue 807) over the region studied and did
not share any nucleotide mutations with other isolates from
this study. In comparison, all other nucleotide mutations
identified in this study were not shared by nucleotide
sequences reported previously from isolates collected in
the northeastern United States during 1999, 2000, or 2001
(9–12). Because these mutations were unique to isolates
sequenced during this study, our results did not show a
closer genetic relationship to isolates from 2001, 2000, or
1999. However, the two isolates in this study that were col-
lected in 2001 (Alabama-1; Alabama-2) did share two
nucleotide mutations (residues 1,442 and 2,466) with 12 of
the other isolates collected in 2002. Construction of a phy-
logenetic tree by maximum parsimony analysis (Figure 3)
illustrates the genetic proximity of isolates from this study
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Table 1. Nucleotide mutations in sequences of the prM-E genes of 22 West Nile virus isolates obtained during 2001 and 2002 compared 
to WN-NY99
a 
prM (501 nt) 
 
Strain 
 
Source 
 
Collected 
 
RNA origin 
491 
(prM9)  507  549  621  660 
679 
(prM72)  690  807  903 
WN-NY99 (AF196835)  Flamingo  06/01/99  Brain  A (Lys)  A  U  A  C  U (Ser)  C  C  G 
Harris Co., TX 
(AY185906) 
Bluejay  06/11/02  Brain/Vero          U         
Harris Co., TX 
(AY185907) 
Bluejay  06/10/02  Brain/Vero          U         
Nueces Co., TX-1  Culex quinquefasciatus  08/06/02  BHK  G        U         
Nueces Co., TX-2  C. quinquefasciatus  09/17/02  BHK          U         
Gregg Co., TX  C. quinquefasciatus  09/25/02  BHK          U         
Tarrant Co., TX  C. restuans  09/30/02  Vero                   
Wichita Co., TX  C. quinquefasciatus  10/23/02  BHK          U         
Randall Co., TX  C. tarsalis  09/18/02  BHK          U         
El Paso Co., TX  C. tarsalis  08/26/02  Vero          U         
Illinois-1  C. pipiens  08/02/02  Vero      A        U     
Illinois-2  Dog  08/01/02  Kidney/Vero    G      U         
Alabama-1  C. quinquefasciatus  10/05/01  Vero                   
Alabama-2  Crow  09/10/01  Brain/Vero                   
Colorado  Red-tailed Hawk  08/01/02  Brain/Vero          U         
Louisiana  C. salinarius  08/06/02  Vero                U   
Galveston Co., TX-1 
(AY185914) 
Bluejay  08/02/02  Vero        G    A       
Galveston Co., TX-2 
(AY185913) 
Bluejay  07/19/02  Vero            A       
Galveston Co., TX-3  C. quinquefasciatus  08/21/02  Vero                   
Jefferson Co., TX-1  C. quinquefasciatus  08/06/02  BHK                   
Jefferson Co., TX-2  C. quinquefasciatus  07/02/02  BHK                  A 
Jefferson Co., TX-3  Human  08/24/02  CSF/Vero                   
Orange Co., TX  C. quinquefasciatus  07/03/02  Vero                  A 
aNucleotide (nt)  numbers correspond to those of WN-NY99 (GenBank accession no. AF196835); in brackets for individual residues are the deduced amino acid changes. to those collected from the northeastern United States in
1999, 2000, and 2001. Branch groupings showed both tem-
poral and geographic separation of isolates, with those col-
lected in the northeastern United States in 1999, 2000, and
2001 representing a distinct clade in relation to isolates col-
lected in 2002. An exception to this grouping is an isolate
from Louisiana collected in 2002, which was grouped with
northeastern United States isolates from 1999 to 2001.
Notably, WNV isolates from the southeastern coast of
Texas also comprise a clade of their own, separating these
isolates from other 2001 and 2002 isolates collected from
various regions within the United States. Arecently report-
ed WNV isolate collected from a Missouri dog in 2002
(GenBank accession no. AY160126) also shared a
nucleotide mutation (residue 2,466 C to U) with the 2002
isolates from this study. Although the entire prM-E gene of
this isolate was not reported, this isolate likely represents
an additional member of the large 2002 clade.
In a previous report concerning the genetic divergence
of WNV since its introduction into the United States,
Beasley et al. (13) described a quasispecies population
within a single WNVisolate from Harris County, Texas. To
determine whether nucleotide mutations that define the
southeast coastal Texas variant were uniform throughout
the quasispecies population of a select isolate, the
WN1751/WN2504APCR product derived from WNV iso-
late Galveston Co., TX-3, was cloned into pGEM-T Easy.
Ten clones were sequenced to obtain homologous regions
of 700 nucleotides, which were then compared with the
Galveston Co., TX-3, consensus sequence. This region
contained the U to C mutation at nucleotide 2154 and the
U to C mutation at nucleotide 2,400. Five of the 10 clones
were identical to the consensus sequence, while the other
five clones each had one or two nucleotide changes from
the consensus sequence for a total of eight nucleotide
changes (Table 3). None of the mutations identified repre-
sented amino acid substitutions and, unlike the 2001–2002
variant population (13), none of the mutations encoded a
stop codon. The maximum nucleotide divergence of indi-
vidual clones was 0.28% (mean = 0.11%). Furthermore,
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Table 2. Nucleotide mutations in sequences of the prM-E gene of 22 West Nile virus isolates obtained during 2001 and 2002 compared to WN-NY99  
Envelope (1,503 ntds) 
  
Strain  969  1,038 1,065 1,071  1,118 
(E51)  1,137  1,179 
(E71) 
1,192 
(E76)  1,293 1,356 1,377  1,442 
(E159)  1,443 1,554 1,557 1,581 1,728 1,830 2,094 2,154 2,190  2,392 
(E476)  2,400 2,466 
WN-NY99 
(AF196835) 
C  U  C  U  C (Ala)  C  A (Lys)  A (Thr)  C  C  C  U (Val)  U  T  C  T  A  T  A  U  U  G (Ala)  U  C 
Harris Co., TX 
(AY185906) 
                      C                    A    U 
Harris Co., TX 
(AY185907) 
    U      U            C                        U 
Nueces Co., TX-1                      U  C                  C      U 
Nueces Co., TX-2          U        U    U  C                        U 
Gregg Co., TX                        C  C                      U 
Tarrant Co., TX    C                    C                        U 
Wichita Co., TX                        C                        U 
Randall Co., TX          U    C          C                        U 
El Paso Co., TX                        C                        U 
Illinois-1                        C                        U 
Illinois-2                        C      U  C    C            U 
Alabama-1                        C                        U 
Alabama-2                        C          T              U 
Colorado                        C              G          U 
Louisiana                                                 
Galveston Co., TX-1 
(AY185914) 
U              G    U                    C      C   
Galveston Co., TX-2 
(AY185913) 
U              G    U                    C      C   
Galveston Co., TX-3  U              G    U        C            C      C   
Jefferson Co., TX-1  U              G    U                    C      C   
Jefferson Co., TX-2  U      C        G    U                    C      C   
Jefferson Co., TX-3  U              G    U                    C      C   
Orange Co., TX  U      C        G    U                    C      C   
aNucleotide numbers correspond to those of WN-NY99 (GenBank accession no. AF196835); in brackets for individual residues are the deduced amino acid changes. 
Figure 2. Phylogram based on maximum parsimony analysis
comparing a 2,004-nucleotide sequence of WN-NY99 (Gen Bank
accession no. AF196835) with 22 West Nile virus isolates collect-
ed during 2001 and 2002.none of the nucleotide changes identified in the five clones
was shared with WNV strains representing the 2001–2002
variant, nor were any nucleotide changes identified at two
of the nucleotide positions that defined the southeastern
coastal Texas variant. These results suggest that none of
the virus genomes existing in a quasispecies population
from WNV isolate Galveston Co., TX-3, contained
nucleotide mutations characteristic of the 2001–2002 vari-
ant identified in this study.
Discussion
Sequence comparisons of a 2,004-nucleotide region of
22 WNV isolates collected during the summer and fall of
2001 and 2002 showed the highest degree of nucleotide
divergence from WN-NY99 to date. Studies by Lanciotti et
al. (9) and Huang et al. (12) have shown that the complete
genomes of several WNV isolates collected in 1999, 2000,
and 2001 share >99.8% nucleotide identity with WN-
NY99, with three or fewer amino acid substitutions in the
entire polyprotein. Similar studies of partial nucleotide
sequences conducted by Anderson et al. (10) and Ebel et
al. (11) reported up to three nucleotide mutations encom-
passing a region of 921 nucleotides and 1,503 nucleotides
from isolates collected in Connecticut in 1999 and 2000
and New York in 2000, respectively. Although our studies
have compared a larger portion of the genome than earlier
studies of partial nucleotide sequences, we have identified
individual isolates with as many as seven nucleotide muta-
tions and three amino acid substitutions, with a maximum
divergence of 0.35% from the homologous region of the
prototype North American WNV, WN-NY99. The
nucleotide mutations identified in this study were not
shared by previously sequenced isolates from 1999, 2000,
or 2001 (9–12) and represent new nucleotide changes in
the North American WNV population. Since these changes
were not shared with other previously reported WNV
sequences, the isolates analyzed in this study did not show
a greater genetic similarity with northeastern isolates from
1999, 2000, or 2001. However, several of these nucleotide
changes (660, 969, 1,356, 2,154, 2,400, and 2,466) are
observed in other Old World WNV strains from both line-
age I and lineage II (Table 4). Each of these changes rep-
resents a noncoding mutation from either a C to U or U to
C in the third codon of the open reading frame; nucleotides
at these positions may revert back to nucleotides observed
in the more ancestral Old World strains.  
Our results also suggest the geographic clustering of
genetically distinct variants. Seven of the 22 isolates, all of
which were collected from coastal regions of southeast
Texas, share five nucleotide mutations unique to only these
isolates. Fourteen of the other isolates, which represent the
CDC-defined East South Central (AL), West South Central
(LAand TX), East North Central (IL), and Mountain (CO)
regions (3), all share two unique nucleotide mutations not
identified in other isolates (Figure 2). The results of this
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Figure 3. Cladogram based on maximum parsimony analysis com-
paring a 2,004-nucleotide sequence of 22 West Nile virus isolates
collected during 2001 and 2002 with a homologous region of WN
virus isolates collected in 1999, 2000, and 2001 from the north-
eastern United States. Numbers indicate bootstrap confidence
estimates based on 500 replicates for clades supported to the
right. Numbers in parenthesis represent GenBank accession num-
bers.
Table 3. Nucleotides that varied among individual clone sequences of a fragment of the E protein gene (genomic positions  
1,769-2,469) of the WNV Galveston Co., TX-3
a,b 
Nucleotide 
Clone  1,779  1,787  1,798  1,871  2,162  2,168  2,232  2,469 
Consensus sequence  U  U  A  A  A  G  A  U 
1      G        G   
2  C  C             
4        G        C 
6          G       
7            A     
aWNV, West Nile virus.  
bClones 3, 5, 8, 9, 10 are identical to the consensus sequence. study support the findings of Beasley et al. (13), which
suggest that during the summer of 2002 WNV was intro-
duced into Texas on at least two separate occasions. These
results might reflect the unique migratory patterns of North
American birds, which act as reservoir hosts for WNV. As
Rappole et al. (14) have illustrated, many North American
birds follow well-documented migration routes from sum-
mer grounds in the northeastern United States to southern
areas that are classified as the southeastern United States,
circum-Gulf, trans-Gulf, and Caribbean/western North
Atlantic routes. For example, the Laughing Gull (Larus
atricilla) has been known to follow a circum-Gulf route as
it travels from the northeastern United States to stopover
sites along the northern and western Gulf Coast on its way
to Mexico or Central America. Because certain species of
birds have a more limited geographic range than others,
geographically clustered populations of distinct genetic
variants, for example, isolates collected from coastal
regions of southeast Texas, might arise as a result of
restricted migratory routes. This hypothesis is supported
by a number of studies. Peiris and Amerasinghe (15) have
identified a group of geographically restricted antigenic
variants of WNV confined to southern India. Because of
the lack of bird migratory routes linking southern India
with the Middle East and Africa, a distinct antigenic group
exists exclusively in southern India. Furthermore, numer-
ous studies have shown antigenic variation among WNV
strains that correlate with geographically distinct regions
and restricted bird migratory patterns (16,17).
Phylogenetic comparisons of Indian viruses with other
WNV strains show similar findings, which place Indian
WNV strains in a unique clade of lineage I (9,18). Recent
studies in Israel by Malkinson et al. (19) also support the
role of migratory birds in the dispersion of unique WNV
variants in geographically distinct regions. The results of
our study support an alternative hypothesis that explains
the continental spread of WNV as a consequence of trans-
mission between local bird and mosquito populations in a
given region. This mechanism allows for spread of the
virus from region to region over shorter distances, in con-
trast to the long distances traveled by migratory birds (20).
Our finding of a dominant variant that exists over a large
part of the United States, together with evidence of a geo-
graphically distinct southeast coastal Texas variant, sug-
gests that both mechanisms of spread have influenced the
genetic distribution and spread of WNV in the United
States.  
To date, little genetic evidence supports or refutes the
hypothesis that WNV becomes established in an enzootic
transmission cycle in a particular geographic area rather
than being reintroduced into a particular area each year
when the transmission season begins. Similarly, because of
the limited published data detailing the year-to-year genet-
ic changes observed in WNV, whether the virus is becom-
ing endemic in particular regions of the United States
remains to be established. This question will be answered
in part by determining baseline phylogenetic results of spe-
cific variants in a geographic area and by analyzing iso-
lates collected in sequential transmission seasons.
Although the isolates analyzed in this study do not rep-
resent the entire temporal and geographic distribution of
WNV in North America, at least some nucleotide muta-
tions have been conserved among WNV strains circulat-
ing across the continent. If indeed the conservation of
these mutations is the result of selective pressure, such as
the continued capacity to replicate in both arthropod and
vertebrate hosts, rather than random mutations occurring
as a consequence of genetic drift, one would expect these
mutations to be conserved in virus isolates collected in
other regions of North America. Further investigation
concerning the genetic composition of viruses from addi-
tional regions of North America will define the extent to
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Table 4. Nucleotide changes from WN-NY99 observed in 2001 and 2002 WNV isolates that are conserved in Old World WNV isolates 
with complete genomes available from GenBank
a,b 
660 (C to U)  969 (C to U)  1,356 (C to U)  2,154 (U to C)  2,400 (U to C)  2,466 (C to U) 
WN Uganda 1937 
(M12294) 
WN IS-98 STD 
(AF481864) 
WN Eg101  WN Uganda 1937  WN Uganda 1937 
 WN LEIV-Krnd88-190 
WN Uganda 1937 
WN LEIV-Krnd88-190 
(AY277251) 
WN Eg101 (AF260968) 
WN Ast99-901 
    WN Eg101  
WN Ast99-901 
 
 
 (AY278441)  
WN LEIV-Krnd88-190 
    WN RO97-50 
(AF260969) 
 
        WN VLG-4 (AF317203)   
 
      WN KN3829 
(AY262283) 
 
 
      WN Italy 1998-equine 
(AF404757) 
 
 
      WN LEIV-Vlg00-27924 
(AY278442) 
 
        WN VLG-4 (AF317203)   
aWNV, West Nile virus. 
bNumber in parenthesis represents GenBank accession no. Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 9, No. 11, November 2003 1429
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which dominant variants have emerged. If dominant vari-
ants do continue to emerge across the United States, phy-
logenetic analyses will help researchers monitor the
spread of WNV in North America and may provide expla-
nations for the rapid and widespread movement of this
newly emerging virus in North America. Similarly, identi-
fying the genetic composition of WNV isolates from other
regions of the United States and Canada, as well as com-
paring these isolates with isolates collected in 2003, will
continue to define evolutionary relationships of WNV cir-
culating in North America and facilitate predictions con-
cerning the primary mechanisms of transmission and
spread of the virus.
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